Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled multicenter study of evolocumab and executive function in statin-treated subjects
2014-001976-75Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypercholesterolemia and dyslipidemia comparing Evolocumab arm with Placebo arm (2 arms). Started Jul 2014; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on 2014-001976-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001976-75.